Abstract
1. The competitive alpha- and beta-adrenoceptor blocking agent labetalol, in concentrations up to 10(-4) M, produced dose-dependent increases in transmitter overflow from the isolated blood perfused spleen of the cat following nerve stimulation at 10 and 30 Hz. 2. At concentrations above 10(-4) M labetol produced a pronounced decrease in transmitter overflow. 3. Labetalol (1.5 X 10(-4) M) increased the recovery of 3H label in the venous blood following the close-arterial infusion of [3H]-(-)-noradrenaline indicating that the drug inhibits uptake of the amine. 4. Both labetalol (3.8 X 10(-5) M) and piperoxan (7.4 X 10(-6) M) produced parallel shifts to the right of the dose-response curves to noradrenaline and oxymetazoline in isolated strips of cat splenic capsule. In this preparation both drugs acted as competitive postsynaptic alpha-adrenoceptor blocking agents. 5. Labetalol (3.3 X 10(-5) M) increased the transmitter overflow following stimulation of the splenic nerves with 200 impulses at 10 Hz. The overflow could be further increased by subsequent addition of piperoxan (7.2 X 10(-6 M). Piperoxan (5.7 X 10(-6) M) alone produced a marked increase in transmitter overflow which could be further increased by subsequent addition of desmethylimipramine (DMI; 3.2 X 10(-5) M). Cocaine (1.5 X 10(-5) M) or DMI (5.4 X 10(-5 M) produced a small increase in transmitter overflow which was not further increased by addition of labetalol (2.8 X 10(-5) M). 6. Labetalol produced a biphasic effect on the responses of the isolated blood perfused spleen of the cat to nerve stimulation. With low doses (up to 10(-4) M) vascular responses were potentiated and with high doses (greater than 10(-4) M) inhibited. The potentiation was related to uptake blockade and the inhibition to decreased transmitter overflow and postsynaptic alpha-adrenoceptor blockade. 7. Labetalol appears to act as a postsynaptic alpha-adrenoceptor antagonist in the isolated blood perfused spleen of the cat with little effect on presynaptic alpha-adrenoceptors. The moderate elevation of transmitter overflow by the drug is related to the inhibitory effect of the drug on neuronal uptake rather than on presynaptic alpha-adrenoceptors.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adler-Graschinsky E., Langer S. Z. Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism. Br J Pharmacol. 1975 Jan;53(1):43–50. doi: 10.1111/j.1476-5381.1975.tb07328.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ariëns E. J. The structure-activity relationships of beta adrenergic drugs and beta adrenergic blocking drugs. Ann N Y Acad Sci. 1967 Feb 10;139(3):606–631. doi: 10.1111/j.1749-6632.1967.tb41232.x. [DOI] [PubMed] [Google Scholar]
- BLAKELEY A. G., BROWN G. L., FERRY C. B. Pharmacological experiments on the release of the sympathetic transmitter. J Physiol. 1963 Jul;167:505–514. doi: 10.1113/jphysiol.1963.sp007165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BROWN G. L., GILLESPIE J. S. The output of sympathetic transmitter from the spleen of the cat. J Physiol. 1957 Aug 29;138(1):81–102. doi: 10.1113/jphysiol.1957.sp005839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bacq Z. M., Blakeley A. G., Summers R. J. The effects of amiodarone, an alpha and beta receptor antiagonist, on adrenergic transmission in the cat spleen. Biochem Pharmacol. 1976 May 15;25(10):1195–1199. doi: 10.1016/0006-2952(76)90368-3. [DOI] [PubMed] [Google Scholar]
- Barrett A. M., Carter J. Comparative chronotropic activity of beta-adrenoceptive antagonists. Br J Pharmacol. 1970 Nov;40(3):373–381. doi: 10.1111/j.1476-5381.1970.tb10619.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Birmingham A. T., Paterson G., Wójcicki J. A comparison of the sensitivities of innervated and denervated rat vasa deferentia to agonist drugs. Br J Pharmacol. 1970 Aug;39(4):748–754. doi: 10.1111/j.1476-5381.1970.tb09901.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blakeley A. G., Brown L., Dearnaley D. P., Woods R. I. Perfusion of the spleen with blood containing prostaglandin E1: transmitter liberation and uptake. Proc R Soc Lond B Biol Sci. 1969 Dec 23;174(1036):281–292. doi: 10.1098/rspb.1969.0094. [DOI] [PubMed] [Google Scholar]
- Blakeley A. G., Powis G., Summers R. J. An uptake mechanism for L-noradrenaline in the cat spleen, associated with the nerves but distinct from uptake. J Physiol. 1974 Apr;238(1):193–206. doi: 10.1113/jphysiol.1974.sp010518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blakeley A. G., Powis G., Summers R. J. The effects of pargyline on overflow of transmitter and uptake of noradrenaline in the cat spleen. Br J Pharmacol. 1973 Apr;47(4):719–728. doi: 10.1111/j.1476-5381.1973.tb08199.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blakeley A. G., Summers R. J. Proceedings: The effects of AH 5158 on the overflow of transmitter and the uptake of (3H)-(--)-noradrenaline in the cat spleen. Br J Pharmacol. 1976 Mar;56(3):364P–365P. [PMC free article] [PubMed] [Google Scholar]
- Cripps H., Dearnaley D. P. Vascular responses and noradrenaline overflows in the isolated blood-perfused cat spleen: some effects of cocaine, normetanephrine and -blocking agents. J Physiol. 1972 Dec;227(3):647–664. doi: 10.1113/jphysiol.1972.sp010052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cubeddu L., Barnes E. M., Langer S. Z., Weiner N. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors. J Pharmacol Exp Ther. 1974 Sep;190(3):431–450. [PubMed] [Google Scholar]
- Davidson W. J., Innes I. R. Dissociation of potentiation of isoprenaline by cocaine from inhibition of uptake in cat spleen. Br J Pharmacol. 1970 May;39(1):175–181. doi: 10.1111/j.1476-5381.1970.tb09567.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dubocovich M. L., Langer S. Z. Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxybenzamine in blocking the pre- and post-synaptic adrenergic receptors. J Physiol. 1974 Mar;237(3):505–519. doi: 10.1113/jphysiol.1974.sp010495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Enero M. A., Langer S. Z., Rothlin R. P., Stefano F. J. Role of the -adrenoceptor in regulating noradrenaline overflow by nerve stimulation. Br J Pharmacol. 1972 Apr;44(4):672–688. doi: 10.1111/j.1476-5381.1972.tb07306.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Farmer J. B., Kennedy I., Levy G. P., Marshall R. J. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors. Br J Pharmacol. 1972 Aug;45(4):660–675. doi: 10.1111/j.1476-5381.1972.tb08125.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Granata A. R., Langer S. Z. Effects of cocaine or denervation on responses of isolated strips of cat spleen to (-)-noradrenaline and (-)-isoprenaline. Br J Pharmacol. 1973 Aug;48(4):667–675. doi: 10.1111/j.1476-5381.1973.tb08255.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guimarães S., Brandão F. Comparison between the effects produced by chronic denervation and by cocaine on the sensitivity to, and on the disposition of, noradrenaline in isolated spleen strips. Naunyn Schmiedebergs Arch Pharmacol. 1973;277(2):163–174. doi: 10.1007/BF00501157. [DOI] [PubMed] [Google Scholar]
- Hughes J. Inhibition of noradrenaline release by lysergic acid diethylamide. Br J Pharmacol. 1973 Dec;49(4):706–708. doi: 10.1111/j.1476-5381.1973.tb08549.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Häggendal J., Johansson B., Jonason J., Ljung B. Effects of phenoxybenzamine on transmitter release and effector response in the isolated portal vein. J Pharm Pharmacol. 1972 Feb;24(2):161–164. doi: 10.1111/j.2042-7158.1972.tb08954.x. [DOI] [PubMed] [Google Scholar]
- Kennedy I., Levy G. P. Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals. Br J Pharmacol. 1975 Apr;53(4):585–592. doi: 10.1111/j.1476-5381.1975.tb07398.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kirpekar S. M., Puig M. Effect of flow-stop on noradrenaline release from normal spleens and spleens treated with cocaine, phentolamine or phenoxybenzamine. Br J Pharmacol. 1971 Oct;43(2):359–369. [PMC free article] [PubMed] [Google Scholar]
- Langer S. Z. Presynaptic regulation of catecholamine release. Biochem Pharmacol. 1974 Jul 1;23(13):1793–1800. doi: 10.1016/0006-2952(74)90187-7. [DOI] [PubMed] [Google Scholar]
- Mujić M., van Rossum J. M. Comparative pharmacodynamics of sympathomimetic imidazolines; studies on intestinal smooth muscle of the rabbit and the cardiovascular system of the cat. Arch Int Pharmacodyn Ther. 1965 Jun;155(2):432–449. [PubMed] [Google Scholar]
- Starke K. Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn Schmiedebergs Arch Pharmacol. 1972;274(1):18–45. doi: 10.1007/BF00501004. [DOI] [PubMed] [Google Scholar]
- Starke K., Endo T., Taube H. D. Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol. 1975;291(1):55–78. doi: 10.1007/BF00510821. [DOI] [PubMed] [Google Scholar]
- Starke K., Montel H., Gayk W., Merker R. Comparison of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. Alpha-sympathomimetic inhibition of Neurogenic vasoconstriction. Naunyn Schmiedebergs Arch Pharmacol. 1974;285(2):133–150. doi: 10.1007/BF00501149. [DOI] [PubMed] [Google Scholar]
- Summers R. J., Tillman J. The effects of AH 5158 on metabolism of 3H(-)noradrenaline released from the cat spleen by nerve stimulation [proceedings]. Br J Pharmacol. 1976 Oct;58(2):280P–281P. [PMC free article] [PubMed] [Google Scholar]
